Published in FEBS Lett on June 04, 1999
A quantitative systems approach reveals dynamic control of tRNA modifications during cellular stress. PLoS Genet (2010) 2.73
tRNA's modifications bring order to gene expression. Curr Opin Microbiol (2008) 2.51
Post-transcriptional nucleotide modification and alternative folding of RNA. Nucleic Acids Res (2006) 2.34
Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins. Nat Commun (2012) 1.93
Human tRNA(Lys3)(UUU) is pre-structured by natural modifications for cognate and wobble codon binding through keto-enol tautomerism. J Mol Biol (2011) 1.82
Translational misreading: a tRNA modification counteracts a +2 ribosomal frameshift. Genes Dev (2001) 1.76
Dimerisation-dependent GTPase reaction of MnmE: how potassium acts as GTPase-activating element. EMBO J (2006) 1.75
Post-transcriptional modification in archaeal tRNAs: identities and phylogenetic relations of nucleotides from mesophilic and hyperthermophilic Methanococcales. Nucleic Acids Res (2001) 1.52
Combined protein construct and synthetic gene engineering for heterologous protein expression and crystallization using Gene Composer. BMC Biotechnol (2009) 1.40
The structure of the TrmE GTP-binding protein and its implications for tRNA modification. EMBO J (2004) 1.34
A sequence element that tunes Escherichia coli tRNA(Ala)(GGC) to ensure accurate decoding. Nat Struct Mol Biol (2009) 1.32
Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry. Nat Protoc (2014) 1.09
The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells. EMBO J (2005) 1.06
An insight into the transcriptome of the digestive tract of the bloodsucking bug, Rhodnius prolixus. PLoS Negl Trop Dis (2014) 1.03
Characterization of Streptococcus pneumoniae TrmD, a tRNA methyltransferase essential for growth. J Bacteriol (2004) 1.01
RNA helicase module in an acetyltransferase that modifies a specific tRNA anticodon. EMBO J (2009) 0.99
High-resolution structure of the nitrile reductase QueF combined with molecular simulations provide insight into enzyme mechanism. J Mol Biol (2010) 0.95
Identification of Streptococcus thermophilus CNRZ368 genes involved in defense against superoxide stress. Appl Environ Microbiol (2004) 0.93
Single-cell time-lapse analysis of depletion of the universally conserved essential protein YgjD. BMC Microbiol (2011) 0.91
Conservation of structure and mechanism by Trm5 enzymes. RNA (2013) 0.89
Structure of a class II TrmH tRNA-modifying enzyme from Aquifex aeolicus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.89
Evaluating the reproducibility of quantifying modified nucleosides from ribonucleic acids by LC-UV-MS. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.88
The role of wobble uridine modifications in +1 translational frameshifting in eukaryotes. Nucleic Acids Res (2015) 0.88
In vivo misreading by tRNA overdose. RNA (2000) 0.87
Role of tautomerism in RNA biochemistry. RNA (2015) 0.87
Novel base-pairing interactions at the tRNA wobble position crucial for accurate reading of the genetic code. Nat Commun (2016) 0.86
Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic. J Mol Biol (2011) 0.85
tRNA-modifying MiaE protein from Salmonella typhimurium is a nonheme diiron monooxygenase. Proc Natl Acad Sci U S A (2007) 0.85
Importance of trmE for growth of the psychrophile Pseudomonas syringae at low temperatures. Appl Environ Microbiol (2009) 0.85
Probing the intermediacy of covalent RNA enzyme complexes in RNA modification enzymes. Methods Enzymol (2007) 0.82
Bacterial transfer RNAs. FEMS Microbiol Rev (2015) 0.81
The MiaA tRNA modification enzyme is necessary for robust RpoS expression in Escherichia coli. J Bacteriol (2013) 0.80
Crystallization and preliminary X-ray crystallographic characterization of TrmFO, a folate-dependent tRNA methyltransferase from Thermotoga maritima. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.79
A Platform for Discovery and Quantification of Modified Ribonucleosides in RNA: Application to Stress-Induced Reprogramming of tRNA Modifications. Methods Enzymol (2015) 0.79
Exploring GpG bases next to anticodon in tRNA subsets. Bioinformation (2013) 0.78
From Prebiotics to Probiotics: The Evolution and Functions of tRNA Modifications. Life (Basel) (2016) 0.78
Hypomodification of the wobble base in tRNAGlu, tRNALys, and tRNAGln suppresses the temperature-sensitive phenotype caused by mutant release factor 1. J Bacteriol (2008) 0.78
Unique cost dynamics elucidate the role of frameshifting errors in promoting translational robustness. Genome Biol Evol (2010) 0.77
Influence of Sequence and Covalent Modifications on Yeast tRNA Dynamics. J Chem Theory Comput (2014) 0.77
Non-canonical roles of tRNAs and tRNA mimics in bacterial cell biology. Mol Microbiol (2016) 0.77
Purification, crystallization and preliminary crystallographic analysis of a 4-thiouridine synthetase-RNA complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.76
The i6A37 tRNA modification is essential for proper decoding of UUX-Leucine codons during rpoS and iraP translation. RNA (2016) 0.75
Crystallization and preliminary crystallographic analysis of tRNA (m(7)G46) methyltransferase from Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.75
Chemical and Conformational Diversity of Modified Nucleosides Affects tRNA Structure and Function. Biomolecules (2017) 0.75
YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis. Front Cell Infect Microbiol (2016) 0.75
Systematic Evolution and Study of UAGN Decoding tRNAs in a Genomically Recoded Bacteria. Sci Rep (2016) 0.75
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (2008) 8.12
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum (1999) 6.39
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Transfer RNA modification. Annu Rev Biochem (1987) 4.63
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (1995) 4.41
Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer (1976) 4.35
The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
Improvement of reading frame maintenance is a common function for several tRNA modifications. EMBO J (2001) 3.80
A massive binary black-hole system in OJ 287 and a test of general relativity. Nature (2008) 3.50
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway. Nat Cell Biol (1999) 3.45
Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG (2006) 3.23
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol (1970) 3.17
A primordial tRNA modification required for the evolution of life? EMBO J (2001) 3.01
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
K562--a human erythroleukemic cell line. Int J Cancer (1979) 2.84
Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res (1982) 2.68
Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins. J Dent Res (1999) 2.50
MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther (2008) 2.43
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst (2000) 2.41
Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol (2001) 2.31
Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol (2000) 2.20
Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection. Lancet (1991) 2.17
Classification and biological nature of established human hematopoietic cell lines. Int J Cancer (1975) 2.16
Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem (1998) 2.13
The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV. Appl Environ Microbiol (2001) 2.11
Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08
High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int J Cancer (1971) 2.06
Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology (2000) 2.03
Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica (1997) 1.98
Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem (1999) 1.90
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res (1999) 1.90
Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol (2001) 1.85
Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer (1977) 1.84
Mechanisms of GDF-5 action during skeletal development. Development (1999) 1.83
The modification of the wobble base of tRNAGlu modulates the translation rate of glutamic acid codons in vivo. J Mol Biol (1998) 1.77
RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins. Proc Natl Acad Sci U S A (1991) 1.74
Nasal continuous positive airway pressure: experiences with a new technical approach. Acta Paediatr (1993) 1.74
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73
Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73
Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer (1974) 1.73
Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet (2001) 1.71
Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost (2005) 1.70
Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene (1994) 1.69
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl Environ Microbiol (1999) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Liver failure due to recombinant alpha interferon. Lancet (1991) 1.64
Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther (2013) 1.64
A new model for phenotypic suppression of frameshift mutations by mutant tRNAs. Mol Cell (1998) 1.63
Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One (2007) 1.61
Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J Biol Chem (1996) 1.59
Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1988) 1.59
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res (2001) 1.59
Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev (1974) 1.57
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis (1996) 1.57
Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J Virol (1994) 1.56
Serum beta-hydroxybutyrate measurement in patients with uncontrolled diabetes mellitus. Arch Intern Med (1999) 1.56
The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int (2001) 1.56
Functional analyses of the promoters in the lantibiotic mutacin II biosynthetic locus in Streptococcus mutans. Appl Environ Microbiol (1999) 1.55
Bacteriophage T4 RNA ligase is gene 63 product, the protein that promotes tail fiber attachment to the baseplate. Proc Natl Acad Sci U S A (1977) 1.54
Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes. Appl Environ Microbiol (2000) 1.53
COPD in Chinese nonsmokers. Eur Respir J (2009) 1.52
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. Drug Metab Dispos (1997) 1.52
Effective use of polymerase chain reaction for diagnosis of central nervous system infections. Clin Infect Dis (1999) 1.51
Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochem J (2001) 1.49
Altered cytochrome c display precedes apoptotic cell death in Drosophila. J Cell Biol (1999) 1.49
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47
Lupus anticoagulant and Klinefelter's syndrome. J Rheumatol (1993) 1.47
IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. J Clin Invest (1995) 1.47
An essential role for the caspase dronc in developmentally programmed cell death in Drosophila. J Biol Chem (2000) 1.46
Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun (1999) 1.46
Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. Southeast Asian J Trop Med Public Health (1980) 1.46
Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. Cell Stress Chaperones (1998) 1.45
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res (2001) 1.44
Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem (1999) 1.44
Activation of the reaper gene during ectopic cell killing in Drosophila. Dev Biol (1996) 1.44
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Natural killer cells kill tumour cells at a given stage of differentiation. Nature (1981) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. Leukemia (1989) 1.42
The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol (1994) 1.40
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39
Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest (1988) 1.38
A 69-year-old woman with recurrent symptomatic pleural effusions. Circulation (1995) 1.38
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother (2001) 1.38
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol (1996) 1.37
Transfer RNA(5-methylaminomethyl-2-thiouridine)-methyltransferase from Escherichia coli K-12 has two enzymatic activities. J Biol Chem (1987) 1.37
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res (1983) 1.37
Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl (2001) 1.35
Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem J (2000) 1.35